NGFN-TRANSFER
Decoy oligodeoxynucleotide drug targets in heart failure
Coordinator: | Dr. Beate Berghöfer | |
Institution: | AVONTEC GmbH, Martinsried | |
Homepage: | www.avontec.com/ |
Primary objective of subproject 1 was the optimization of already developed decoy ODNs against the transcription factors AP-1 and NF-IL6, including the development of appropriate control oligonucleotides. After the withdrawal of the industrial partner AVONTEC GmbH effective on 31.12.2009 the subproject was gradually integrated into subproject 2 under the direction of Prof. Hecker.
Additional relevant Internet-links:
Institut für Physiologie und Pathophysiologie, Universität Heidelberg
Abt. Innere Medizin III: Kardiologie, Angiologie und Pneumologie
Additional relevant Internet-links:
Institut für Physiologie und Pathophysiologie, Universität Heidelberg
Abt. Innere Medizin III: Kardiologie, Angiologie und Pneumologie
KTT
MEDIA
CURRENT
NGFN-MEETING-2012
NGFN- MEETING
NGFN1&2
LINKS